| 摘要 |
The present invention discloses a novel polypeptide - human L-3-phosphoserine phosphatase 10.01 and a polynucleotide encoding the same, as well as a method of producing the polypeptide by DNA recombinant technique. The present invention also discloses methods of using the polypeptide in treatment of various disease, such as heart failure, vision disorder, muscular atrophy, amyasthenia, muscular tetany and so on. The present invention also discloses an antagonist against the polypeptide and the therapeutic use of the same. The present invention also discloses the use of such polynucleotide encoding human L-3-phosphoserine phosphatase 10.01.
|
